221 related articles for article (PubMed ID: 18843278)
21. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.
Sperveslage J; Frank S; Heneweer C; Egberts J; Schniewind B; Buchholz M; Bergmann F; Giese N; Munding J; Hahn SA; Kalthoff H; Klöppel G; Sipos B
Int J Cancer; 2012 Aug; 131(4):E371-81. PubMed ID: 22020953
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
23. Glypican-3 and KRT19 are markers associating with metastasis and poor prognosis of pancreatic ductal adenocarcinoma.
Yao H; Yang Z; Liu Z; Miao X; Yang L; Li D; Zou Q; Yuan Y
Cancer Biomark; 2016; 17(4):397-404. PubMed ID: 27689616
[TBL] [Abstract][Full Text] [Related]
24. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
[TBL] [Abstract][Full Text] [Related]
25. Levels of HOXB7 and miR-337 in pancreatic ductal adenocarcinoma patients.
Zhang R; Zheng S; Du Y; Wang Y; Zang W; Zhao G
Diagn Pathol; 2014 Mar; 9():61. PubMed ID: 24641834
[TBL] [Abstract][Full Text] [Related]
26. Expression of Calretinin, Marker of Mesothelial Differentiation, in Pancreatic Ductal Adenocarcinoma: A Potential Diagnostic Pitfall.
Askan G; Basturk O
Turk Patoloji Derg; 2021; 37(2):115-120. PubMed ID: 33432559
[TBL] [Abstract][Full Text] [Related]
27. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
[TBL] [Abstract][Full Text] [Related]
28. Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma.
Welsch T; Keleg S; Bergmann F; Bauer S; Hinz U; Schmidt J
Pancreas; 2009 Nov; 38(8):968-76. PubMed ID: 19672209
[TBL] [Abstract][Full Text] [Related]
29. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
30. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of FZD1 and CAIX are Associated with Invasion, Metastasis, and Poor-Prognosis of the Pancreatic Ductal Adenocarcinoma.
Yang L; Yang Z; Li D; Liu Z; Zou Q; Yuan Y; Xu H
Pathol Oncol Res; 2018 Oct; 24(4):899-906. PubMed ID: 28921449
[TBL] [Abstract][Full Text] [Related]
33. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma.
Jiang NY; Woda BA; Banner BF; Whalen GF; Dresser KA; Lu D
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1648-52. PubMed ID: 18628415
[TBL] [Abstract][Full Text] [Related]
34. Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma.
Bergmann F; Wandschneider F; Sipos B; Moldenhauer G; Schniewind B; Welsch T; Schirrmacher P; Klöppel G; Altevogt P; Schäfer H; Sebens Müerköster S
Oncol Rep; 2010 Oct; 24(4):909-15. PubMed ID: 20811670
[TBL] [Abstract][Full Text] [Related]
35. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
36. Stromal expression of hemopexin is associated with lymph-node metastasis in pancreatic ductal adenocarcinoma.
Suzuki Y; Takadate T; Mizuma M; Shima H; Suzuki T; Tachibana T; Shimura M; Hata T; Iseki M; Kawaguchi K; Aoki T; Hayashi H; Morikawa T; Nakagawa K; Motoi F; Naitoh T; Igarashi K; Unno M
PLoS One; 2020; 15(7):e0235904. PubMed ID: 32663208
[TBL] [Abstract][Full Text] [Related]
37. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.
Xue YZ; Sheng YY; Liu ZL; Wei ZQ; Cao HY; Wu YM; Lu YF; Yu LH; Li JP; Li ZS
Tumour Biol; 2013 Apr; 34(2):895-9. PubMed ID: 23247867
[TBL] [Abstract][Full Text] [Related]
38. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of pancreatitis-associated protein (PAP) in human pancreatic ductal adenocarcinoma.
Xie MJ; Motoo Y; Iovanna JL; Su SB; Ohtsubo K; Matsubara F; Sawabu N
Dig Dis Sci; 2003 Mar; 48(3):459-64. PubMed ID: 12757156
[TBL] [Abstract][Full Text] [Related]
40. Stromal hyaluronan accumulation is associated with low tumor grade and nodal metastases in pancreatic ductal adenocarcinoma.
Larson BK; Guan M; Placencio V; Tuli R; Hendifar AE
Hum Pathol; 2019 Aug; 90():37-44. PubMed ID: 31121193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
